The first well-documented case of HIV pre-exposure prophylaxis (PrEP) failure "provides a cautionary note to those both prescribing and receiving PrEP," according to Paul Sax, M.D.
ABOUT THIS SERIES: HIV prevention continues to evolve, as options expand and the science improves. This spotlight series aims to help providers better understand today's prevention, with focus on best practices and relevant factors to consider when working with patients regarding prevention. The spotlight also includes news and analysis on the latest HIV prevention science, including safer sex, pre-exposure prophylaxis (PrEP) and treatment as prevention (TasP).
TheBodyPRO.com is a service of Remedy Health Media, LLC, 750 3rd Avenue, 6th Floor, New York, NY 10017. TheBodyPRO.com and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of TheBodyPRO.com's homepage, topic pages, page designs and HTML code. General Disclaimer: TheBodyPRO.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBodyPRO.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.